LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq PR Newswire BEIJING, Sept. 12, ...
BEIJING, Sept. 12, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results